A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau)

Is further screening of men with baseline PSA 

(2015) Marco Randazzo et al.   INTERNATIONAL JOURNAL OF CANCER

The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era

(2015) Jaquelyn L. Jahn et al.   INTERNATIONAL JOURNAL OF CANCER

Family History of Prostate Cancer in Men Being Followed by Active Surveillance Does Not Increase Risk of Being Diagnosed With High-grade Disease

(2015) Christina G. Selkirk et al.   UROLOGY

A rare 8q24 single nucleotide polymorphism (SNP) predisposes North American men to prostate cancer and possibly more aggressive disease

(2014) Boris Grin et al.   BJU INTERNATIONAL

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Family history in the Finnish Prostate Cancer Screening Trial

(2014) Lasse Saarimäki et al.   INTERNATIONAL JOURNAL OF CANCER

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

(2014) Fritz H Schröder et al.   LANCET

Prevalence of theHOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy

(2013) Jennifer L. Beebe-Dimmer et al.   BJU INTERNATIONAL

A comparison of US and Australian men’s values and preferences for PSA screening

(2013) Kirsten Howard et al.   BMC HEALTH SERVICES RESEARCH

The population impact of familial cancer, a major cause of cancer

(2013) Christoph Frank et al.   INTERNATIONAL JOURNAL OF CANCER

Early Detection of Prostate Cancer: AUA Guideline

(2013) H. Ballentine Carter et al.   JOURNAL OF UROLOGY

Patient Demographics, Quality of Life, and Disease Features of Men With Newly Diagnosed Prostate Cancer: Trends in the PSA Era

(2013) Allison S. Glass et al.   UROLOGY

Do Adenocarcinomas of the Prostate With Gleason Score (GS)≤6 Have the Potential to Metastasize to Lymph Nodes?

(2012) Hillary M. Ross et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review

(2012) Saskia Van der Meer et al.   BMC Family Practice

Prostate-specific Antigen (PSA) Testing Is Prevalent and Increasing in Stockholm County, Sweden, Despite No Recommendations for PSA Screening: Results from a Population-based Study, 2003–2011

(2012) Tobias Nordström et al.   EUROPEAN UROLOGY

Prostate-Cancer Mortality at 11 Years of Follow-up

(2012) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prostate cancer risk in men with prostate and breast cancer family history: results from the REDUCE study (R1)

(2011) J.-A. Thomas et al.   JOURNAL OF INTERNAL MEDICINE

Estimates of cancer incidence and mortality in Europe in 2008

(2010) J. Ferlay et al.   EUROPEAN JOURNAL OF CANCER

Age-Specific Risk of Incident Prostate Cancer and Risk of Death from Prostate Cancer Defined by the Number of Affected Family Members

(2010) Andreas Brandt et al.   EUROPEAN UROLOGY

Effects of Prostate-Specific Antigen Testing on Familial Prostate Cancer Risk Estimates

(2010) O. Bratt et al.   JNCI-Journal of the National Cancer Institute

Effect of Dutasteride on the Risk of Prostate Cancer

(2010) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevalence of Family History of Breast, Colorectal, Prostate, and Lung Cancer in a Population-Based Study

(2010) P.L. Mai et al.   Public Health Genomics